Details of Drug

Drug General Information (ID: D1715)
Drug Name	Zalcitabine
Drug Type	Small molecule
Drug Synonymous	zalcitabine; Dideoxycytidine; 7481-89-2; 2',3'-DIDEOXYCYTIDINE; ddCyd; HIVID; ddC; Cytidine, 2',3'-dideoxy-; Zalcitibine; 4-Amino-1-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; 2,3-dideoxycytidine; NSC 606170; UNII-6L3XT8CB3I; CCRIS 692; HSDB 7156; C9H13N3O3; Ro-24-2027/000; Ro 24-2027/000; CHEMBL853; BRN 0654956; 6L3XT8CB3I; CHEBI:10101; 1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine; WREGKURFCTUGRC-POYBYMJQSA-N; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one; MFCD00012188; DdC; DdCyd; D 5782; DDC (DDC); DdC & Interferon alpha; DdC & sCD4; DdC (Antiviral); Hivid (TN); Hivid(TM); Interferon AD + ddC; KS-1130; SRI-7707; Beta-D-DDC; DS-4152 & ddC; DdC & GM-CSF; DdC & IFN-alpha; DdC & NP (from PHCA or HSA); PC-SOD & ddC; Zalcitabine [USAN:INN:BAN]; Hivid, Dideoxycytidine, NSC 606170, Zalcitabine; Zalcitabine (JAN/USP/INN); Beta-D-2',3'-Dideoxycytidine; Cytidine, 2',3'-dideoxy & Interferon alpha; Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxycytidine; Cytidine, 2',3'-dideoxy-& Colony-stimulating factor; Beta-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor; Lecithinized superoxide dismutase & beta-D-2',3'-Dideoxycytidine; 2',3'-Dideoxycytidine & Interferon-alpha; 2',3'-Dideoxycytidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate); 2',3'-Dideoxycytidine & sCD4(soluble recombinant protein); 3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; DdC Click to Show/Hide
Disease Class	1C60-1C62: Human immunodeficiency virus disease
Therapeutic Class	Anti-Hiv Agents
Structure
Structure	3D Structure		2D Structure
Formula	C9H13N3O3
InChI	1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1
InChIKey	WREGKURFCTUGRC-POYBYMJQSA-N
Canonical SMILES	C1CC(OC1CO)N2C=CC(=NC2=O)N
External Link
	Pubchem ID	24066
	CAS Number	7481-89-2
	CHEBI ID	10101
	TTD ID	D0Z9QR
	INTEDE ID	DR1724
	VARIDT ID	DR00175

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM005 Affected excretion pathways AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM009 Altered absorption (Unspecific) BM010 Transporter inhibition BM017 CYP450 enzyme inhibition BM028 Competitive inhibition of renal tubular secretion BM055 Increased risk of hepatotoxicity BM070 Increased risk of metabolic acidosis BM074 Increased risk of peripheral neuropathy BM107 Attenuated pharmacological effects (Unspecific) BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Zalcitabine
Affected gastrointestinal absorption
	Altered absorption (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1187		Orlistat	C29H53NO5	3034010	Moderate		Inter Info	[52]
Affected cellular transport
	Transporter inhibition					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1528		Tafamidis	C14H7Cl2NO3	11001318	Moderate		Inter Info	[1], [57], [58]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0375		Cobicistat	C40H53N7O5S2	25151504	Moderate		Inter Info	[3], [1], [44], [45], [46], [47], [48], [18], [49], [50]
Affected excretion pathways
	Competitive inhibition of renal tubular secretion					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1241		Pemetrexed	C20H21N5O6	135410875	Moderate		Inter Info	[26]
D1645		Trimethoprim	C14H18N4O3	5578	Moderate		Inter Info	[1], [32], [5]
D1341		Probenecid	C13H19NO4S	4911	Moderate		Inter Info	[12], [5], [53]
Pharmacodynamic additive effects
	Increased risk of hepatotoxicity					Drug Num: 21
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[6], [7], [8]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[9]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[10]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[11]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[6], [7], [8]
D0114		Asparaginase Escherichia coli	NA	NA	Moderate		Inter Info	[13], [3], [14]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[17], [18]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[3], [1], [19]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[20], [21], [22], [23]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[20], [21], [22], [23]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[1], [24]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[25]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[30], [31]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[33], [13], [34], [3], [1], [35], [36], [37], [38], [39], [40], [14], [41]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Moderate		Inter Info	[42]
D0232		Calaspargase pegol	NA	NA	Moderate		Inter Info	[33], [13], [34], [3], [1], [35], [36], [37], [38], [39], [40], [14], [41]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[1], [43]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[51]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[20], [21], [22], [23]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[3], [1], [54], [55], [56]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[1], [59]
	Increased risk of metabolic acidosis					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1397		Ribavirin	C8H12N4O5	37542	Moderate		Inter Info	[27], [28], [29]
	Increased risk of peripheral neuropathy					Drug Num: 70
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0023		Adalimumab	NA	NA	Moderate		Inter Info	[12], [5]
D0193		Bortezomib	C19H25BN4O4	387447	Moderate		Inter Info	[12], [5]
D0303		Cerivastatin	C26H34FNO5	446156	Moderate		Inter Info	[12], [5]
D0313		Chloramphenicol	C11H12Cl2N2O5	5959	Moderate		Inter Info	[12], [5]
D0320		Chloroquine	C18H26ClN3	2719	Moderate		Inter Info	[12], [5]
D0344		Cisplatin	Cl2H6N2Pt	5702198	Moderate		Inter Info	[12], [5]
D0419		Dapsone	C12H12N2O2S	2955	Moderate		Inter Info	[12], [5]
D0483		Didanosine	C10H12N4O3	135398739	Moderate		Inter Info	[12], [5]
D0509		Disulfiram	C10H20N2S4	3117	Moderate		Inter Info	[12], [5]
D0616		Ethambutol	C10H24N2O2	14052	Moderate		Inter Info	[12], [5]
D1731		Ethionamide	C8H10N2S	2761171	Moderate		Inter Info	[12], [5]
D0627		Etoposide	C29H32O13	36462	Moderate		Inter Info	[12], [5]
D0802		Infliximab	NA	NA	Moderate		Inter Info	[12], [5]
D0821		Interferon alfa-2a, Recombinant	NA	NA	Moderate		Inter Info	[12], [5]
D0822		Interferon alfa-2b	C16H17Cl3I2N3NaO5S	71306834	Moderate		Inter Info	[12], [5]
D0824		Interferon alfa-n1	NA	NA	Moderate		Inter Info	[12], [5]
D0823		Interferon alfacon-1	NA	NA	Moderate		Inter Info	[12], [5]
D0933		Linezolid	C16H20FN3O4	441401	Moderate		Inter Info	[12], [5]
D0956		Lovastatin	C24H36O5	53232	Moderate		Inter Info	[12], [5]
D1051		Metronidazole	C6H9N3O3	4173	Moderate		Inter Info	[12], [5]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[12], [5]
D1329		Pravastatin	C23H36O7	54687	Moderate		Inter Info	[12], [5]
D1473		Simvastatin	C25H38O5	54454	Moderate		Inter Info	[12], [5]
D1504		Stavudine	C10H12N2O4	18283	Moderate		Inter Info	[12], [5]
D1551		Teniposide	C32H32O13S	452548	Moderate		Inter Info	[12], [5]
D1587		Tinidazole	C8H13N3O4S	5479	Moderate		Inter Info	[12], [5]
D1698		Vincristine	C46H56N4O10	5978	Moderate		Inter Info	[12], [5]
D1699		Vincristine (liposome)	C46H56N4O10	5978	Moderate		Inter Info	[12], [5]
D1700		Vinorelbine	C45H54N4O8	5311497	Moderate		Inter Info	[12], [5]
D1714		Zafirlukast	C31H33N3O6S	5717	Moderate		Inter Info	[12], [5]
D0066		Amiodarone	C25H29I2NO3	2157	Moderate		Inter Info	[12], [5]
D0120		Atorvastatin	C33H35FN2O5	60823	Moderate		Inter Info	[12], [5]
D0126		Auranofin	C20H34AuO9PS	24199313	Moderate		Inter Info	[12], [5]
D0127		Aurothioglucose	C6H11AuO5S	454937	Moderate		Inter Info	[12], [5]
D0162		Benznidazole	C12H12N4O3	31593	Moderate		Inter Info	[12], [5]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[12], [5]
D0227		Cabazitaxel	C45H57NO14	9854073	Moderate		Inter Info	[12], [5]
D0260		Carboplatin	C6H12N2O4Pt	426756	Moderate		Inter Info	[12], [5]
D0261		Carfilzomib	C40H57N5O7	11556711	Moderate		Inter Info	[12], [5]
D0304		Certolizumab pegol	NA	NA	Moderate		Inter Info	[12], [5]
D0380		Colchicine	C22H25NO6	6167	Moderate		Inter Info	[12], [5]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Moderate		Inter Info	[12], [5]
D0496		Diiodohydroxyquinoline	C9H5I2NO	3728	Moderate		Inter Info	[12], [5]
D0511		Docetaxel	C43H53NO14	148124	Moderate		Inter Info	[12], [5]
D0560		Elotuzumab	NA	NA	Moderate		Inter Info	[12], [5]
D0571		Enfortumab vedotin	NA	NA	Moderate		Inter Info	[12], [5]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[12], [5]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[12], [5]
D0669		Fludarabine	C10H12FN5O4	657237	Moderate		Inter Info	[12], [5]
D0686		Fluvastatin	C24H26FNO4	446155	Moderate		Inter Info	[12], [5]
D0736		Golimumab	NA	NA	Moderate		Inter Info	[12], [5]
D0770		Hydralazine	C8H8N4	3637	Moderate		Inter Info	[12], [5]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Moderate		Inter Info	[12], [5]
D0841		Ipilimumab	NA	NA	Moderate		Inter Info	[12], [5]
D0858		Isoniazid	C6H7N3O	3767	Moderate		Inter Info	[12], [5]
D0873		Ixabepilone	C27H42N2O5S	6445540	Moderate		Inter Info	[12], [5]
D0874		Ixazomib	C14H19BCl2N2O4	25183872	Moderate		Inter Info	[12], [5]
D0918		Levodopa	C9H11NO4	6047	Moderate		Inter Info	[12], [5]
D1118		Nelarabine	C11H15N5O5	3011155	Moderate		Inter Info	[12], [5]
D1212		Paclitaxel	C47H51NO14	36314	Moderate		Inter Info	[12], [5]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Moderate		Inter Info	[12], [5]
D1301		Pitavastatin	C25H24FNO4	5282452	Moderate		Inter Info	[12], [5]
D1306		Polatuzumab vedotin	NA	NA	Moderate		Inter Info	[12], [5]
D1312		Pomalidomide	C13H11N3O4	134780	Moderate		Inter Info	[12], [5]
D1313		Ponatinib	C29H27F3N6O	24826799	Moderate		Inter Info	[12], [5]
D1430		Rosuvastatin	C22H28FN3O6S	446157	Moderate		Inter Info	[12], [5]
D1479		Sodium aurothiomalate	C4H3AuNa2O4S	22318	Moderate		Inter Info	[12], [5]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[12], [5]
D1599		Tocilizumab	NA	NA	Moderate		Inter Info	[12], [5]
D1623		Trastuzumab emtansine	NA	NA	Moderate		Inter Info	[12], [5]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0178		Bexarotene	C24H28O2	82146	Major		Inter Info	[1], [2]
D1246		Pentamidine	C19H24N4O2	4735	Major		Inter Info	[3], [1], [5]
Pharmacodynamic antagonistic effects
	Attenuated pharmacological effects (Unspecific)					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0566		Emtricitabine	C8H10FN3O3S	60877	Major		Inter Info	[3], [1], [4]
D0889		Lamivudine	C8H11N3O3S	60825	Major		Inter Info	[3], [1], [4]
D0348		Cladribine	C10H12ClN5O3	20279	Moderate		Inter Info	[1], [15], [16]

References
1	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
2	Product Information. Targretin (bexarotene) Ligand Pharmaceuticals, San Diego, CA.
3	Cerner Multum, Inc. "Australian Product Information.".
4	Veal GJ, Hoggard PG, Barry MG, Khoo S, Back DJ "Interaction between lamivudine (3TC) and other nucleoside analogues for intracellular phosphorylation." AIDS 10 (1996): 546-8.[PMID: 8724049]
5	Product Information. Hivid (zalcitabine). Roche Laboratories, Nutley, NJ.
6	Canadian Pharmacists Association.
7	EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
8	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
9	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
10	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
11	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
12	Argov Z, Mastaglia FL "Drug-induced peripheral neuropathies." Br Med J 1 (1979): 663-6. [PMID: 219931]
13	Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
14	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
15	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
16	Product Information. Leustatin (cladribine). Ortho Biotech Inc, Raritan, NJ.
17	Elsharkawy AM, Schwab U, McCarron B, et al. "Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser." J Clin Virol 58 (2013): 331-3. [PMID: 23763943]
18	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
19	Product Information. Ellence (epirubicin) Pharmacia and Upjohn, Kalamazoo, MI.
20	Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
21	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
22	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
23	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
24	Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
25	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
26	Product Information. Alimta (pemetrexed). Lilly, Eli and Company, Indianapolis, IN.
27	Guyader D, Poinsignon Y, Cano Y, Saout L "Fatal lactic acidosis in a HIV-positive patient treated with interferon and ribavirin for chronic hepatitis C." J Hepatol 37 (2002): 289-91. [PMID: 12127440]
28	Product Information. Copegus (ribavirin). Roche Laboratories, Nutley, NJ.
29	Product Information. Rebetron (interferon-alfa-2b-ribavirin). Schering Laboratories, Kenilworth, NJ.
30	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
31	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
32	Multum Information Services, Inc. Expert Review Panel.
33	Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
34	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
35	Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
36	Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
37	Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
38	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
39	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
40	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
41	Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
42	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
43	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
44	Product Information. Evotaz (atazanavir-cobicistat). Bristol-Myers Squibb, Princeton, NJ.
45	Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
46	Product Information. Prezcobix (cobicistat-darunavir). Janssen Pharmaceuticals, Titusville, NJ.
47	Product Information. Prezista (darunavir). Ortho Biotech Inc, Bridgewater, NJ.
48	Product Information. Stribild (cobicistat/elvitegravir/emtricitabine/tenofov). Gilead Sciences, Foster City, CA.
49	Product Information. Tybost (cobicistat). Gilead Sciences, Foster City, CA.
50	Product Information. Viramune (nevirapine). Boehringer-Ingelheim, Ridgefield, CT.
51	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
52	MHRA. Medicines and Healthcare Products Regulatory Agency "Orlistat: theoretical interaction with antiretroviral HIV medicines.".
53	Massarella JW, Nazareno LA, Passe S, Min B "The effect of probenecid on the pharmacokinetics of zalcitabine in HIV-positive patients." Pharmaceut Res 13 (1996): 449-52
54	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
55	Gilead Sciences, Inc "About Remdesivir.".
56	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
57	Product Information. Vyndaqel (tafamidis). Pfizer U.S. Pharmaceuticals Group, New York, NY.
58	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA."
59	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence